Ubiquitin-specific protease 54 (USP54) inhibits glycolysis and tumor cell growth by reducing p53-mediated GLUT1 expression and ameliorates the malignant phenotype and poor survival of LUAD patients (Chen L. et al., 2024). The gene discussed is SLC2A1; the disease is neoplasm.